Abstract:Cancer continually remains a severe threat to public health and requires constant demand for novel therapeutic drug candidates. Due to their multi-target orientation, lesser toxicity, and easy availability, natural compounds attract more attention from current scientific research interest than synthetic drug molecules. The plants and microorganisms produce a huge variety of secondary metabolites because of their physiological diversification, and the seaweeds occupy a prominent position as effective drug resources. Seaweeds comprise microscopic or macroscopic photosynthetic, multicellular, eukaryotic marine algae that commonly inhabit the coastal regions. Several molecules (such as polysaccharides, lipids, proteinaceous fractions, phenolic compounds, and alkaloids) are derived from seaweeds, and those small molecules are well attractive and more effective in cancer research programs. Their structural variation, derivative diversity, and quantity vary with seaweed species and geographical origin. Their smaller molecular weight, unique derivatives, hydrophobicity, and degree of sulfation are reported to be causes of their crucial role against different cancer cells in vitro. Several reports showed that those compounds selectively discriminate between normal and cancer cells based on receptor variations, enzyme deficiency, and structural properties. The present review aimed to give a concise explanation regarding their structural diversity, extractability, and mechanism of action related to their anti-cancer activities based on recently published data.

An Overview of the Mechanisms of Marine Fungi-Derived Anti-Inflammatory and Anti-Tumor Agents and Their Novel Role in Drug Targeting

Progress on the bioactive secondary metabolites from marine fungi

Marine Fungi-Derived Secondary Metabolites: Potential as Future Drugs for Health Care

Marine-Derived Metabolites Act as Promising Antifungal Agents

Natural bioactive compounds from marine fungi (2017–2020)

Natural Products from Marine-Derived Fungi with Anti-Inflammatory Activity

Extremophilic Fungi from Marine Environments: Underexplored Sources of Antitumor, Anti-Infective and Other Biologically Active Agents

Seaweeds and Their Secondary Metabolites: A Promising Drug Candidate With Novel Mechanisms Against Cancers and Tumor Angiogenesis

Novel Bioactive Compounds From Marine Sources as a Tool for Functional Food Development

A Review of Anti-Inflammatory Compounds from Marine Fungi, 2000–2018

A Brief Review of Bioactive Metabolites Derived from Deep-Sea Fungi

Deep-Sea-Derived Fungi as Valuable Producers of Cytotoxic Secondary Metabolites and Their Leads Potential

Marine Natural Products with Anti-Inflammation Effects

Marine Fungi Bioactives with Anti-Inflammatory, Antithrombotic and Antioxidant Health-Promoting Properties Against Inflammation-Related Chronic Diseases

Marine Drugs: A Hidden Wealth and a New Epoch for Cancer Management

An Update Review of Secondary Metabolites from Marine Fungi.

Deep-Sea Fungi Could Be the New Arsenal for Bioactive Molecules.

Cytotoxic Compounds from Marine Fungi: Sources, Structures, and Bioactivity

Potential of Anti-Cancer Activity of Secondary Metabolic Products from Marine Fungi

The Chemotherapeutic Potentials of Compounds Isolated from the Plant, Marine, Fungus, and Microorganism: Their Mechanism of Action and Prospects

Advances in secondary metabolites of fungi isolated from the marine alga